Last Updated: May 10, 2026

Claims for Patent: 5,753,677


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,753,677
Title:Benzoheterocyclic compounds
Abstract:Novel benzoheterocyclic compounds of the formula: ##STR1## which have excellent vasopressin antagonistic activities and are useful as vasodilator, hypotensive agent, water diuretics, platelet agglutination inhibitor, and a vasopressin antagonistic composition containing the compound as the active ingredient.
Inventor(s):Hidenori Ogawa, Hisashi Miyamoto, Kazumi Kondo, Hiroshi Yamashita, Kenji Nakaya, Hajime Komatsu, Michinori Tanaka, Shinya Kora, Michiaki Tominaga, Yoichi Yabuuchi
Assignee: Otsuka Pharmaceutical Co Ltd
Application Number:US08/474,544
Patent Claims: 1. A method for antagonizing vasopressin which comprises administering to a subject a therapeutically effective amount of a benzoheterocyclic compound of the formula: ##STR3330## wherein R1 is a hydrogen atom, a halogen atom, a C1 -C6 alkyl, an amino having optionally a C1 -C6 alkyl substituent, or a C1 -C6 alkoxy,R2 is a hydrogen atom, a halogen atom, a C1 -C6 alkoxy, a phenyl-(C1 -C6) alkoxy, hydroxy, a C1 -C6 alkyl, an amino having optionally a C1 -C6 alkyl substituent, a carbamoyl-substituted C1 -C6 alkoxy, an amino-substituted C1 -C6 alkoxy having optionally a C1 -C6 alkyl substituent, or a benzoyloxy which has optionally a halogen substituent on the phenyl ring, R3 is a group of the formula: ##STR3331## or a group of the formula: ##STR3332## R4 is a hydrogen atom, a benzoyl which has optionally a halogen substituent on the phenyl ring or a C1 -C6 alkyl, R5 is a group of the formula: ##STR3333## wherein R16 is a halogen atom; a C1 -C6 alkyl which has optionally a substituent selected from a halogen atom and hydroxy; hydroxy; a C1 -C6 alkoxy; a C1 -C6 alkanoyloxy; a C1 -C6 alkylthio; a C1 -C6 alkanoyl; carboxy; a C1 -C6 alkoxycarbonyl; cyano; nitro; an amino which has optionally a substituent selected from a C1 -C6 alkyl and a C1 -C6 alkanoyl; phenyl; a C3 -C8 cycloalkyl; a C2 -C6 alkanoyloxy-substituted C1 -C6 alkoxy; a carboxy-substituted C1 -C6 alkoxy; a halogen-substituted C1 -C6 alkoxy; a carbamoyl-substituted C1 -C6 alkoxy; a hydroxy-substituted C1 -C6 alkoxy; a C1 -C6 alkoxycarbonyl-substituted C1 -C6 alkoxy; a phthalimido-substituted C1 -C6 alkoxy; an aminocarbonyl-(C1 -C6) alkoxy having a C1 -C6 alkyl substituent; or a group of the formula: ##STR3334## wherein A is a C1 -C6 alkylene, and R6 and R7 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl having optionally a hydroxy substituent, a C1 -C6 alkanoyl, or benzoyl, or R6 and R7 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from piperidinyl and a C1 -C6 alkyl; and m is an integer of 0 to 3, a phenyl-(C1 -C6) alkoxycarbonyl, a C1 -C6 alkanoyl, a phenyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkylcarbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C2 -C6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C1 -C6 alkyl, a C1 -C6 alkoxy and an amino having optionally a C1 -C6 alkanoyl substituent, a phthalimido-substituted C2 -C6 alkanoyl, a C1 -C6 alkoxycarbonyl-(C2 -C6) alkanoyl, a carboxy-(C2 -C6) alkanoyl, a naphthyloxy-(C2 -C6) alkanoyl, a halogen-substituted C1 -C6 alkanoyl, a group of the formula: ##STR3335## wherein R8 is a hydrogen atom, a C1 -C6 alkyl, a phenyl-(C1 -C6) alkoxycarbonyl, a carbamoyl-(C1 -C6) alkyl, an amino-(C2 -C6) alkanoyl having optionally a C1 -C6 alkyl substituent, or a C1 -C6 alkanoyl, an anilinocarbonyl which has optionally a C1 -C6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C1 -C6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3336## wherein B is a C1 -C6 alkylene, n is an integer of 0 or 1, and R9 and R10 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl having optionally a hydroxy substituent, a C3 -C8 cycloalkyl, a phenyl-(C1 -C6) alkyl, a C1 -C6 alkanoyl, a C2 -C6 alkenyl, a phenoxy-(C1 -C6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C1 -C6 alkyl, a C1 -C6 alkoxy and a halogen atom, a phthalimido-substituted C1 -C6 alkyl, an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C2 -C6 alkynyl, or an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkyl substituent, or R9 and R10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C1 -C6 alkyl, a C1 -C6 alkoxycarbonyl and piperidinyl, R11 is a hydrogen atom or a C1 -C6 alkyl, R12 is a C3 -C8 cycloalkyl, or a phenyl which has optionally 1 to 3 substituents selected from a C1 -C6 alkoxy, a C1 -C6 alkyl and a halogen atom, W is a group of the formula: --(CH2)p -- wherein p is an integer of 3 to 5, or a group of the formula: --CH═CH--(CH2)q -- wherein q is an integer of 1 to 3, and further said --(CH2)p -- group and said --CH═CH--(CH2)q -- group having optionally 1 to 3 substituents selected from a C1 -C6 alkyl having optionally a hydroxy substituent, a C1 -C6 alkoxycarbonyl, carboxy, hydroxy, oxo, a C1 -C6 alkanoyloxy having optionally a halogen substituent, an amino-(C1 -C6) alkyl having optionally a substituent selected from a C1 -C6 alkyl and a C1 -C6 alkanoyl, a C1 -C6 alkanoyloxy-substituted C1 -C6 alkyl, a C1 -C6 alkylsulfonyloxy-(C1 -C6) alkyl, an azido-(C1 -C6) alkyl, a group of the formula: ##STR3337## an aminocarbonyloxy having optionally a C1 -C6 alkyl substituent, a C1 -C6 alkoxy, a C1 -C6 alkoxycarbonyl-substituted C1 -C6 alkoxy, a carboxy-substituted C1 -C6 alkoxy, an aminocarbonyl-(C1 -C6) alkoxy having optionally a C1 -C6 alkyl substituent, an amino-(C1 -C6) alkoxy having optionally a substituent selected from a C1 -C6 alkyl and a C1 -C6 alkanoyl, a phthalimido-substituted C1 -C6 alkoxy, hydroxy-imino, a C1 -C6 alkanoyloxy-imino, a C1 -C6 alkylidene, a halogen atom, azido, sulfoxyimino, a group of the formula: ##STR3338## wherein R81 is a hydrogen atom or a C1 -C6 alkyl, hydrazino, pyrrolyl, an amino-(C2 -C6) alkanoyloxy having optionally a C1 -C6 alkyl substituent, a group of the formula: ##STR3339## wherein A is as defined above in this claim, and R82 and R83 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl, a carbamoyl-substituted C1 -C6 alkyl, a hydroxy-substituted C1 -C6 alkyl, or a pyridyl-(C1 -C6) alkyl, or R82 and R83 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen, oxygen or sulfur atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, morpholino, and thiomorpholino, and has optionally a substituent selected from oxo, a C1 -C6 alkyl, a C1 -C6 alkanoyl, and carbamoyl, and a group of the formula: ##STR3340## wherein n is as defined above in this claim, and R14 and R15 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl, a C2 -C6 alkenyl, a C1 -C6 alkanoyl, a C3 -C8 cycloalkyl, an oxiranyl-substituted C1 -C6 alkyl, a C1 -C6 alkyl having 1 to 2 substituents selected from a C1 -C6 alkoxy, hydroxy and an amino having optionally a C1 -C6 alkyl substituent, a phenyl-(C1 -C6) alkyl, a pyridyl-(C1 -C6) alkyl, a C1 -C6 alkylsulfonyl, benzoyl, a C1 -C6 alkoxycarbonyl, anilinocarbonyl, an aminocarbonyl having optionally a C1 -C6 alkyl substituent, a cyano-substituted C1 -C6 alkyl, a C1 -C6 alkoxycarbonyl-substituted C1 -C6 alkyl, a carbamoyl-substituted C1 -C6 alkyl, a carboxy-substituted C1 -C6 alkyl, a tetrahydropyranyloxy-substituted C1 -C6 alkyl, a C1 -C6 alkanoyloxy-substituted C1 -C6 alkyl, a piperidinyl having optionally a phenyl-(C1 -C6) alkyl substituent on the piperidine ring, a halogen substituted C1 -C6 alkanoyl, an imidazolyl-substituted C2 -C6 alkanoyl, an amino-(C2 -C6) alkanoyl having optionally a substituent selected from a C1 -C6 alkyl and a C1 -C6 alkoxycarbonyl, an aminocarbonyl-(C1 -C6) alkyl having optionally a C1 -C6 alkyl substituent, or a phenyl-(C1 -C6) alkoxycarbonyl, or R14 or R15 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or oxygen atom, wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, and morpholino, and may optionally have a substituent selected from a C1 -C6 alkyl, a phenyl-(C1 -C6) alkyl or a C1 -C6 alkanoyl, and a pharmaceutically acceptable salt thereof.

2. The method according to claim 1, wherein R1 is a hydrogen atom.

3. The method according to claim 1, wherein R1 is a halogen atom.

4. The method according to claim 1, wherein R1 is a C1 -C6 alkyl, an amino having optionally a C1 -C6 alkyl substituent, or a C1 -C6 alkoxy.

5. The method according to claim 2, wherein R2 is a hydrogen atom.

6. The method according to claim 2, wherein R2 is a halogen atom, a C1 -C6 alkoxy, or a C1 -C6 alkyl.

7. The method according to claim 2, wherein R2 is a phenyl-(C1 -C6) alkoxy, hydroxy, an amino having optionally a C1 -C6 alkyl substituent, a carbamoyl-substituted C1 -C6 alkoxy, an amino-substituted C1 -C6 alkoxy having optionally a C1 -C6 alkyl substituent, or a benzoyloxy having optionally a halogen substituent on the phenyl ring.

8. The method according to claim 3, wherein R2 is a hydrogen atom.

9. The method according to claim 3, wherein R2 is a halogen atom, a C1 -C6 alkoxy, or a C1 -C6 alkyl.

10. The method according to claim 3, wherein R2 is a phenyl-(C1 -C6) alkoxy, hydroxy, an amino having optionally a C1 -C6 alkyl substituent, a carbamoyl-substituted C1 -C6 alkoxy, an amino-substituted C1 -C6 alkoxy having optionally a C1 -C6 alkyl substituent, or a benzoyloxy having optionally a halogen substituent on the phenyl ring.

11. The method according to claim 4, wherein R2 is a hydrogen atom.

12. The method according to claim 4, wherein R2 is a halogen atom, a C1 -C6 alkoxy, or a C1 -C6 alkyl.

13. The method according to claim 4, wherein R2 is a phenyl-(C1 -C6) alkoxy, hydroxy, an amino having optionally a C1 -C6 alkyl substituent, a carbamoyl-substituted C1 -C6 alkoxy, an amino-substituted C1 -C6 alkoxy having optionally a C1 -C6 alkyl substituent, or a benzoyloxy having optionally a halogen substituent on the phenyl ring.

14. The method according to claim 5, wherein R3 is a group of the formula: ##STR3341## wherein R4 and R5 are as defined in claim 1.

15. The method according to claim 5, wherein R3 is a group of the formula: ##STR3342## wherein R11 and R12 are as defined in claim 1.

16. The method according to claim 6, wherein R3 is a group of the formula: ##STR3343## wherein R4 and R5 are as defined in claim 1.

17. The method according to claim 6, wherein R3 is a group of the formula: ##STR3344## wherein R11 and R12 are as defined in claim 1.

18. The method according to claim 8, wherein R3 is a group of the formula: ##STR3345## wherein R4 and R5 are as defined in claim 1.

19. The method according to claim 8, wherein R3 is a group of the formula: ##STR3346## wherein R11 and R12 are as defined in claim 1.

20. The method according to claim 9, wherein R3 is a group of the formula: ##STR3347## wherein R4 and R5 are as defined in claim 1.

21. The method according to claim 9, wherein R3 is a group of the formula: ##STR3348## wherein R11 and R12 are as defined in claim 1.

22. The method according to claim 14, wherein R4 is a hydrogen atom, and R5 is a group of the formula: ##STR3349## and R16 and m are as defined in claim 1.

23. The method according to claim 14, wherein R4 is a hydrogen atom and R5 is a phenyl-(C1 -C6) alkoxycarbonyl, a C1 -C6 alkanoyl, a phenyl(C2 -C6) alkanoyl, a C3 -C8 cycloalkyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkyl-carbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C2 -C6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C1 -C6 alkyl, a C1 -C6 alkoxy and an amino having optionally a C1 -C6 alkanoyl substituent, a phthalimido-substituted C2 -C6 alkanoyl, a C1 -C6 alkoxycarbonyl-(C2 -C6) alkanoyl, a carboxy-(C2 -C6) alkanoyl, a naphthyloxy-(C2 -C6) alkanoyl, a halogen-substituted C1 -C6 alkanoyl, a group of the formula: ##STR3350## wherein R8 is a hydrogen atom, a C1 -C6 alkyl, a phenyl-(C1 -C6)alkoxycarbonyl, a carbamoyl-(C1 -C6) alkyl, an amino-(C2 -C6) alkanoyl having optionally a C1 -C6 alkyl substituent, or a C1 -C6 alkanoyl, an anilinocarbonyl which has optionally a C1 -C6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C1 -C6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3351## wherein B is a C1 -C6 alkylene, n is an integer of 0 or 1, and R9 and R10 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl having optionally a hydroxy substituent, a C3 -C8 cycloalkyl, a phenyl-(C1 -C6) alkyl, a C1 -C6 alkanoyl, a C2 -C6 alkenyl, a phenoxy-(C1 -C6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C1 -C6 alkyl, a C1 -C6 alkoxy and a halogen atom, a phthalimido-substituted C1 -C6 alkyl, an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C2 -C6 alkynyl, or an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkyl substituent, or R9 and R10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C1 -C6 alkyl, a C1 -C6 alkoxycarbonyl and piperidinyl.

24. The method according to claim 14, wherein R4 is a C1 -C6 alkyl.

25. The method according to claim 16, wherein R4 is a hydrogen atom, and R5 is a group of the formula: ##STR3352## wherein R16 and m are as defined in claim 1.

26. The method according to claim 16, wherein R4 is a hydrogen atom, and R5 is a phenyl-(C1 -C6) alkoxycarbonyl, a C1 -C6 alkanoyl, a phenyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkylcarbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C2 -C6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C1 -C6 alkyl, a C1 -C6 alkoxy and an amino having optionally a C1 -C6 alkanoyl substituent, a phthalimido-substituted C2 -C6 alkanoyl, a C1 -C6 alkoxycarbonyl-(C2 -C6) alkanoyl, a carboxy-(C2 -C6) alkanoyl, a naphthyloxy-(C2 -C6) alkanoyl, a halogen-substituted C1 -C6 alkanoyl, a group of the formula: ##STR3353## wherein R8 is a hydrogen atom, a C1 -C6 alkyl, a phenyl-(C1 -C6) alkoxycarbonyl, a carbamoyl-(C1 -C6) alkyl, an amino-(C2 -C6) alkanoyl having optionally a C1 -C6 alkyl substituent, or a C1 -C6 alkanoyl, an anilinocarbonyl which has optionally a C1 -C6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C1 -C6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3354## wherein B is a C1 -C6 alkylene, n is an integer of 0 or 1, and R9 and R10 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl having optionally a hydroxy substituent, a C3 -C8 cycloalkyl, a phenyl-(C1 -C6) alkyl, a C1 -C6 alkanoyl, a C2 -C6 alkenyl, a phenoxy-(C1 -C6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C1 -C6 alkyl, a C1 -C6 alkoxy and a halogen atom, a phthalimido-substituted C1 -C6 alkyl, an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C2 -C6 alkynyl, or an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkyl substituent, or R9 and R10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C1 -C6 alkyl, a C1 -C6 alkoxycarbonyl and piperidinyl.

27. The method according to claim 16, wherein R4 is a C1 -C6 alkyl.

28. The method according to claim 7, wherein R4 is a hydrogen atom, and R5 is a group of the formula: ##STR3355## wherein R16 and m are as defined in claim 1.

29. The method according to claim 7, wherein R4 is a hydrogen atom, and R5 is a phenyl-(C1 -C6) alkoxycarbonyl, a C1 -C6 alkanoyl, a phenyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkylcarbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C2 -C6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C1 -C6 alkyl, a C1 -C6 alkoxy and an amino having optionally a C1 -C6 alkanoyl substituent, a phthalimido-substituted C2 -C6 alkanoyl, a C1 -C6 alkoxycarbonyl-(C2 -C6) alkanoyl, a carboxy-(C2 -C6) alkanoyl, a naphthyloxy-(C2 -C6) alkanoyl, a halogen-substituted C1 -C6 alkanoyl, a group of the formula: ##STR3356## wherein R8 is a hydrogen atom, a C1 -C6 alkyl, a phenyl-(C1 -C6) alkoxycarbonyl, a carbamoyl-(C1 -C6) alkyl, an amino-(C2 -C6) alkanoyl having optionally a C1 -C6 alkyl substituent, or a C1 -C6 alkanoyl, an anilinocarbonyl which has optionally a C1 -C6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C1 -C6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3357## wherein B is a C1 -C6 alkylene, n is an integer of 0 or 1, and R9 and R10 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl having optionally a hydroxy substituent, a C3 -C8 cycloalkyl, a phenyl-(C1 -C6) alkyl, a C1 -C6 alkanoyl, a C2 -C6 alkenyl, a phenoxy-(C1 -C6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C1 -C6 alkyl, a C1 -C6 alkoxy and a halogen atom, a phthalimido-substituted C1 -C6 alkyl, an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C2 -C6 alkynyl, or an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkyl substituent, or R9 and R10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C1 -C6 alkyl, a C1 -C6 alkoxycarbonyl and piperidinyl.

30. The method according to claim 7, wherein R4 is a C1 -C6 alkyl.

31. The method according to claim 18, wherein R4 is a hydrogen atom, R5 is a group of the formula: ##STR3358## wherein R16 and m are as defined in claim 1.

32. The method according to claim 18, wherein R4 is hydrogen atom, and R5 is a phenyl-(C1 -C6) alkoxycarbonyl, a C1 -C6 alkanoyl, a phenyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkylcarbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C2 -C6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C1 -C6 alkyl, a C1 -C6 alkoxy and an amino having optionally a C1 -C6 alkanoyl substituent, a phthalimido-substituted C2 -C6 alkanoyl, a C1 -C6 alkoxycarbonyl-(C2 -C6) alkanoyl, a carboxy-(C2 -C6) alkanoyl, a naphthyloxy-(C2 -C6) alkanoyl, a halogen-substituted (C1 -C6) alkanoyl, a group of the formula: ##STR3359## wherein R8 is a hydrogen atom, a C1 -C6 alkyl, a phenyl-(C1 -C6) alkoxycarbonyl, a carbamoyl-(C1 -C6) alkyl, an amino-(C2 -C6) alkanoyl having optionally a C1 -C6 alkyl substituent, or a C1 -C6 alkanoyl), an anilinocarbonyl which has optionally a C1 -C6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C1 -C6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3360## wherein B is a C1 -C6 alkylene, n is an integer of 0 or 1, and R9 and R10 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl having optionally a hydroxy substituent, a C3 -C8 cycloalkyl, a phenyl-(C1 -C6) alkyl, a C1 -C6 alkanoyl, a C2 -C6 alkenyl, a phenoxy-(C1 -C6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C1 -C6 alkyl, a C1 -C6 alkoxy and a halogen atom, a phthalimido-substituted C1 -C6 alkyl, an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C2 -C6 alkynyl, or an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkyl substituent, or R9 and R10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C1 -C6 alkyl, a C1 -C6 alkoxycarbonyl and piperidinyl.

33. The method according to claim 18, wherein R4 is a C1 -C6 alkyl.

34. The method according to claim 20, wherein R4 is a hydrogen atom, and R5 is a group of the formula: ##STR3361## wherein R16 and m are as defined in claim 1.

35. The method according to claim 20, wherein R4 is a hydrogen atom, and R5 is a phenyl-(C1 -C6) alkoxycarbonyl, a C1 -C6 alkanoyl, a phenyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkyl-carbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C2 -C6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C1 -C6 alkyl, a C1 -C6 alkoxy and an amino having optionally a C1 -C6 alkanoyl substituent, a phthalimido-substituted C2 -C6 alkanoyl, a C1 -C6 alkoxycarbonyl-(C2 -C6) alkanoyl, a carboxy-(C2 -C6) alkanoyl, a naphthyloxy-(C2 -C6) alkanoyl, a halogen-substituted C1 -C6 alkanoyl, a group of the formula: ##STR3362## wherein R8 is a hydrogen atom, a C1 -C6 alkyl, a phenyl-(C1 -C6) alkoxycarbonyl, a carbamoyl-(C1 -C6) alkyl, an amino-(C1 -C6) alkanoyl having optionally a C1 -C6 alkyl substituent, or a C1 -C6 alkanoyl, an anilinocarbonyl which has optionally a C1 -C6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C1 -C6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3363## wherein B is a C1 -C6 alkylene, n is an integer of 0 or 1, and R9 and R10 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl having optionally a hydroxy substituent, a C3 -C8 cycloalkyl, a phenyl-(C1 -C6) alkyl, a C1 -C6 alkanoyl, a C2 -C6 alkenyl, a phenoxy-(C1 -C6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C1 -C6 alkyl, a C1 -C6 alkoxy and a halogen atom, a phthalimido-substituted C1 -C6 alkyl, an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C2 -C6 alkynyl, or an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkyl substituent, or R9 and R10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C1 -C6 alkyl, a C1 C6 alkoxycarbonyl and piperidinyl.

36. The method according to claim 20, wherein R4 is a C1 -C6 alkyl.

37. The method according to claim 10, wherein R4 is a hydrogen atom, and R5 is a group of the formula: ##STR3364## wherein R16 and m are as defined in claim 1.

38. The method according to claim 10, wherein R4 is a hydrogen atom, and R5 is a phenyl-(C1 -C6) alkoxycarbonyl, a C1 -C6 alkanoyl, a phenyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkyl-carbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C2 -C6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C1 -C6 alkyl, a C1 -C6 alkoxy and an amino having optionally a C1 -C6 alkanoyl substituent, a phthalimido-substituted C2 -C6 alkanoyl, a C1 -C6 alkoxycarbonyl-(C2 -C6) alkanoyl, a carboxy-(C2 -C6) alkanoyl, a naphthyloxy-(C2 -C6) alkanoyl, a halogen-substituted C1 -C6 alkanoyl, a group of the formula: ##STR3365## wherein R8 is a hydrogen atom, a C1 -C6 alkyl, a phenyl-(C1 -C6) alkoxycarbonyl, a carbamoyl-(C1 -C6) alkyl, an amino-(C2 -C6) alkanoyl having optionally a C1 -C6 alkyl substituent, or a C1 -C6 alkanoyl, an anilinocarbonyl which has optionally a C1 -C6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C1 -C6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3366## wherein B is a C1 -C6 alkylene, n is an integer of 0 or 1, and R9 and R10 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl having optionally a hydroxy substituent, a C3 -C8 cycloalkyl, a phenyl-(C1 -C6) alkyl, a C1 -C6 alkanoyl, a C2 -C6 alkenyl, a phenoxy-(C1 -C6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C1 -C6 alkyl, a C1 -C6 alkoxy and a halogen atom, a phthalimido-substituted C1 -C6 alkyl, an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C2 -C6 alkynyl, or an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkyl substituent, or R9 and R10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C1 -C6 alkyl, a C1 -C6 alkoxycarbonyl and piperidinyl.

39. The method according to claim 10, wherein R4 is a C1 -C6 alkyl.

40. The method according to claim 11, wherein R4 is a hydrogen atom, and R5 is a group of the formula: ##STR3367## wherein R16 and m are as defined in claim 1.

41. The method according to claim 11, wherein R4 is a hydrogen atom, and R5 is a phenyl-(C1 -C6) alkoxycarbonyl, a C1 -C6 alkanoyl, a phenyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkyl-carbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C2 -C6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C1 -C6 alkyl, a C1 -C6 alkoxy and an amino having optionally a C1 -C6 alkanoyl substituent, a phthalimido-substituted C2 -C6 alkanoyl, a C1 -C6 alkoxycarbonyl-(C2 -C6) alkanoyl, a carboxy-(C2 -C6) alkanoyl, a naphthyloxy-(C2 -C6) alkanoyl, a halogen-substituted C1 -C6 alkanoyl, a group of the formula: ##STR3368## wherein R8 is a hydrogen atom, a C1 -C6 alkyl, a phenyl-(C1 -C6) alkoxycarbonyl, a carbamoyl-(C1 -C6) alkyl, an amino-(C2 -C6) alkanoyl having optionally a C1 -C6 alkyl substituent, or a C1 -C6 alkanoyl, an anilinocarbonyl which has optionally a C1 -C6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C1 -C6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3369## wherein B is a C1 -C6 alkylene, n is an integer of 0 or 1, and R9 and R10 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl having optionally a hydroxy substituent, a C2 -C8 cycloalkyl, a phenyl-(C1 -C6) alkyl, a C1 -C6 alkanoyl, a C2 -C6 alkenyl, a phenoxy-(C1 -C6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C1 -C6 alkyl, a C1 -C6 alkoxy and a halogen atom, a phthalimido-substituted C1 -C6 alkyl, an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C2 -C6 alkynyl, or an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkyl substituent, or R9 and R10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C1 -C6 alkyl, a C1 -C6 alkoxycarbonyl and piperidinyl.

42. The method according to claim 12, wherein R4 is a C1 -C6 alkyl.

43. The method according to claim 12, wherein R4 is a hydrogen atom, and R5 is a group of the formula: ##STR3370## wherein R16 and m are as defined in claim 1.

44. The method according to claim 12, wherein R4 is a hydrogen atom, and R5 is a phenyl-(C1 -C6) alkoxycarbonyl, a C1 -C6 alkanoyl, a phenyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkyl-carbonyl, tricyclo(3.3.1.1)decanylcarbonyl,naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C2 -C6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C1 -C6 alkyl, a C1 -C6 alkoxy and an amino having optionally a C1 -C6 alkanoyl substituent, a phthalimido-substituted C2 -C6 alkanoyl, a C1 -C6 alkoxycarbonyl-(C2 -C6) alkanoyl, a carboxy-(C2 -C6) alkanoyl, a naphthyloxy-(C2 -C6) alkanoyl, a halogen-substituted C1 -C6 alkanoyl, a group of the formula: ##STR3371## wherein R8 is a hydrogen atom, a C1 -C6 alkyl, a phenyl-(C1 -C6) alkoxycarbonyl, a carbamoyl-(C1 -C6) alkyl, an amino-(C2 -C6) alkanoyl having optionally a C1 -C6 alkyl substituent, or a C1 -C6 alkanoyl, an anilinocarbonyl which has optionally a C1 -C6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C1 -C6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3372## wherein B is a C1 -C6 alkylene, n is an integer of 0 or 1, and R9 and R10 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl having optionally a hydroxy substituent, a C3 -C8 cycloalkyl, a phenyl-(C1 -C6) alkyl, a C1 -C6 alkanoyl, a C2 -C6 alkenyl, a phenoxy-(C1 -C6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C1 -C6 alkyl, a C1 -C6 alkoxy and a halogen atom, a phthalimido-substituted C1 -C6 alkyl, an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C2 -C6 alkynyl, or an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkyl substituent, or R9 and R10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C1 -C6 alkyl, a C1 -C6 alkoxycarbonyl and piperidinyl.

45. The method according to claim 12, wherein R4 is a C1 -C6 alkyl.

46. The method according to claim 13, wherein R4 is a hydrogen atom, and R5 is a group of the formula: ##STR3373## wherein R16 and m are as defined in claim 1.

47. The method according to claim 13, wherein R4 is a hydrogen atom, and R5 is a phenyl-(C1 -C6) alkoxycarbonyl, a C1 -C6 alkanoyl, a phenyl(C2 -C6) alkanoyl, a C3 -C8 cycloalkyl-(C2 -C6) alkanoyl, a C3 -C8 cycloalkylcarbonyl, tricyclo(3.3.1.1)decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-(C2 -C6) alkanoyl which phenyl ring has optionally 1 to 3 substituents selected from a C1 -C6 alkyl, a C1 -C6 alkoxy and an amino having optionally a C1 -C6 alkanoyl substituent, a phthalimido-substituted C2 -C6 alkanoyl, a C1 -C6 alkoxycarbonyl-(C2 -C6) alkanoyl, a carboxy-(C2 -C6) alkanoyl, a naphthyloxy-(C2 -C6) alkanoyl, a halogen-substituted C1 -C6 alkanoyl, a group of the formula: ##STR3374## wherein R8 is a hydrogen atom, a C1 -C6 alkyl, a phenyl-(C1 -C6) alkoxycarbonyl, a carbamoyl-(C1 -C6) alkyl, an amino-(C2 -C6) alkanoyl having optionally a C1 -C6 alkyl substituent, or a C1 -C6 alkanoyl, an anilinocarbonyl which has optionally a C1 -C6 alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a C1 -C6 alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: ##STR3375## wherein B is a C1 -C6 alkylene, n is an integer of 0 or 1, and R9 and R10 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl having optionally a hydroxy substituent, a C3 -C8 cycloalkyl, a phenyl-(C1 -C6) alkyl, a C1 -C6 alkanoyl, a C2 -C6 alkenyl, a phenoxy-(C1 -C6) alkyl, a phenyl which has optionally 1 to 3 substituents selected from an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C1 -C6 alkyl, a C1 -C6 alkoxy and a halogen atom, a phthalimido-substituted C1 -C6 alkyl, an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkanoyl substituent, a C2 -C6 alkynyl, or an amino-(C1 -C6) alkyl having optionally a C1 -C6 alkyl substituent, or R9 and R10 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or an oxygen atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl and morpholino, and has optionally a substituent selected from a C1 -C6 alkyl, a C1 -C6 alkoxycarbonyl and piperidinyl.

48. The method according to claim 13, wherein R4 is a C1 -C6 alkyl.

49. The method according to claim 22, wherein R16 is a halogen atom, or a C1 -C6 alkyl having optionally a substituent selected from a halogen atom and hydroxy.

50. The method according to claim 25, wherein R16 is a halogen atom, or a C1 -C6 alkyl having optionally a substituent selected from a halogen atom and hydroxy.

51. The method according to claim 31, wherein R16 is a halogen atom, or a C1 -C6 alkyl having optionally a substituent selected from a halogen atom and hydroxy.

52. The method according to claim 34, wherein R16 is a halogen atom, or a C1 -C6 alkyl having optionally a substituent selected from a halogen atom and hydroxy.

53. The method according to claim 1, wherein W is a group of the formula: --(CH2)p -- wherein p is an integer of 3 to 5, and further said --(CH2)p -- group has optionally 1 to 3 substituents selected from a C1 -C6 alkyl having optionally a hydroxy substituent, a C1 -C6 alkoxycarbonyl, carboxy, hydroxy, oxo, a C1 -C6 alkanoyloxy having optionally a halogen substituent, an amino-(C1 -C6) alkyl having optionally a substituent selected from a C1 -C6 alkyl and a C1 -C6 alkanoyl, a C1 -C6 alkanoyloxy-substituted C1 -C6 alkyl, a C1 -C6 alkylsulfonyloxy-(C1 -C6) alkyl, an azido-(C1 -C6) alkyl, a group of the formula: ##STR3376## an aminocarbonyloxy having optionally a C1 -C6 alkyl substituent, a C1 -C6 alkoxy, a C1 -C6 alkoxycarbonyl-substituted C1 -C6 alkoxy, a carboxy-substituted C-C6 alkoxy, an amino-carbonyl-(C1 -C6) alkoxy having optionally a C1 -C6 alkyl substituent, an amino-(C1 -C6) alkoxy having optionally a substituent selected from a C1 -C6 alkyl and a C1 -C6 alkanoyl, a phthalimido-substituted C1 -C6 alkoxy, hydroxyimino, a C1 -C6 alkanoyloxy-imino, a C1 -C6 alkylidene, a halogen atom, azido, sulfoxy-imino, a group of the formula: ##STR3377## wherein R81 is a hydrogen atom or a C1 -C6 alkyl, hydrazino, pyrrolyl, an amino-(C2 -C6) alkanoyloxy having optionally a C1 -C6 alkyl substituent, a group of the formula: ##STR3378## wherein A is as defined above, and R82 and R83 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl, a carbamoyl-substituted C1 -C6 alkyl, a hydroxy-substituted C1 -C6 alkyl, or a pyridyl-(C1 -C6) alkyl, or R82 and R83 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen, oxygen or sulfur atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, morpholino, and thiomorpholino, and has optionally a substituent selected from oxo, a C1 -C6 alkyl, a C1 -C6 alkanoyl, and carbamoyl, and a group of the formula: ##STR3379## wherein n is as defined above, and R14 and R15 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl, a C2 -C6 alkenyl, a C1 -C6 alkanoyl, a C3 -C8 cycloalkyl, an oxiranyl-substituted C1 -C6 alkyl, a C1 -C6 alkyl having 1 to 2 substituents selected from a C1 -C6 alkoxy, hydroxy and an amino having optionally a C1 -C6 alkyl substituent, a phenyl-(C1 -C6) alkyl, a pyridyl-(C1 -C6) alkyl, a C1 -C6 alkylsulfonyl, benzoyl, a C1 -C6 alkoxycarbonyl, anilinocarbonyl, an aminocarbonyl having optionally a C1 -C6 alkyl substituent, a cyano-substituted C1 -C6 alkyl, a C1 -C6 alkoxycarbonyl-substituted C1 -C6 alkyl, a carbamoyl-substituted C1 -C6 alkyl, a carboxy-substituted C1 -C6 alkyl, a tetrahydropyranyloxy-substituted C1 -C6 alkyl, a C1 -C6 alkanoyloxy-substituted C1 -C6 alkyl, a piperidinyl having optionally a phenyl-(C1 -C6) alkyl substituent on the piperidine ring, a halogen-substituted C1 -C6 alkanoyl, an imidazolyl-substituted C2 -C6 alkanoyl, an amino-(C2 -C6) alkanoyl having optionally a substituent selected from a C1 -C6 alkyl and a C1 -C6 alkoxycarbonyl, an aminocarbonyl-(C1 -C6) alkyl having optionally a C1 -C6 alkyl substituent, or a phenyl-(C1 -C6) alkoxycarbonyl, or R14 or R15 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or oxygen atom, wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, and morpholino, and may optionally have a substituent selected from a C1 -C6 alkyl, a phenyl-(C1 -C6) alkyl or a C1 -C6 alkanoyl.

54. The method according to claim 1, wherein W is a group of the formula: --CH═CH--(CH2)q -- wherein q is an integer of 1 to 3, and further said --CH═CH--(CH2)q -- group has optionally 1 to 3 substituents selected from a C1 -C6 alkyl having optionally a hydroxy substituent, a C1 -C6 alkoxycarbonyl, carboxy, hydroxy, oxo, a C1 -C6 alkanoyloxy having optionally a halogen substituent, an amino-(C1 -C6) alkyl having optionally substituent selected from a C1 -C6 alkyl and a C1 -C6 alkanoyl, a C1 -C6 alkanoyloxy-substituted C1 -C6 alkyl, a C1 -C6 alkylsulfonyloxy -(C1 -C6) alkyl, an azido --(C1 -C6) alkyl, a group of the formula: ##STR3380## an aminocarbonyloxy having optionally a C1 -C6 alkyl substituent, a C1 -C6 alkoxy, a C1 -C6 alkoxycarbonyl-substituted C1 -C6 alkoxy, a carboxy-substituted C1 -C6 alkoxy, an aminocarbonyl-(C1 -C6) alkoxy having optionally a C1 -C6 alkyl substituent, an amino-(C1 -C6) alkoxy having optionally a substituent selected from a C1 -C6 alkyl and a C1 -C6 alkanoyl, a phthalimido-substituted C1 -C6 alkoxy, hydroxyimino, a C1 -C6 alkanoyloxy-imino, a C1 -C6 alkylidene, a halogen atom, azido, sulfoxyimino, a group of the formula: ##STR3381## wherein R18 is a hydrogen atom or a C1 -C6 alkyl, hydrazino, pyrrolyl, an amino-(C2 -C6) alkanoyloxy having optionally a C1 -C6 alkyl substituent, a group of the formula: ##STR3382## wherein A is as defined above, and R82 and R83 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl, a carbamoyl-substituted C1 -C6 alkyl, a hydroxy-substituted C1 -C6 alkyl, or a pyridyl-(C1 -C6) alkyl, or R82 and R83 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen, oxygen or sulfur atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, morpholino, and thiomorpholino, and has optionally a substituent selected from oxo, a C1 -C6 alkyl, a C1 -C6 alkanoyl, and carbamoyl, and a group of the formula: ##STR3383## wherein n is as defined above, and R14 and R15 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl, a C2 -C6 alkenyl, a C1 -C6 alkanoyl, a C3 -C8 cycloalkyl, an oxiranyl-substituted C1 -C6 alkyl, a C1 -C6 alkyl having 1 to 2 substituents selected from a C1 -C6 alkoxy, hydroxy and an amino having optionally a C1 -C6 alkyl substituent, a phenyl-(C1 -C6) alkyl, a pyridyl-(C1 -C6) alkyl, a C1 -C6 alkylsulfonyl, benzoyl, a C1 -C6 alkoxycarbonyl, anilinocarbonyl, an aminocarbonyl having optionally a C1 -C6 alkyl substituent, a cyano-substituted C1 -C6 alkyl, a C1 -C6 alkoxycarbonyl-substituted C1 -C6 alkyl, a carbamoyl-substituted C1 -C6 alkyl, a carboxy-substituted C1 -C6 alkyl, a tetrahydropyranyloxy-substituted C1 -C6 alkyl, a C1 -C6 alkanoyloxy-substituted C1 -C6 alkyl, a piperidinyl having optionally a phenyl-(C1 -C6) alkyl substituent on the piperidine ring, a halogen-substituted C1 -C6 alkanoyl, an imidazolyl-substituted C2 -C6 alkanoyl, an amino-(C2 -C6) alkanoyl having optionally a substituent selected from a C1 -C6 alkyl and a C1 -C6 alkoxycarbonyl, an aminocarbonyl-(C1 -C6) alkyl having optionally a C1 -C6 alkyl substituent, or a phenyl-(C1 -C6) alkoxycarbonyl, or R14 or R15 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen atom or an oxygen atom, wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, and morpholino, and may optionally have a substituent selected from a C1 -C6 alkyl, a phenyl-(C1 -C6) alkyl or a C1 -C6 alkanoyl.

55. The method according to claim 53, wherein W is a group of the formula: --(CH2)p -- wherein p is an integer of 3 to 5, and said --(CH2)p -- group has optionally 1 to 3 substituents selected from a C1 -C6 alkyl having optionally a hydroxy substituent, a C1 -C6 alkoxycarbonyl, carboxy, hydroxy, oxo, a C1 -C6 alkanoyloxy having optionally a halogen substituent, an amino-(C1 -C6) alkyl having optionally a substituent selected from a C1 -C6 alkyl and a C1 -C6 alkanoyl, a C1 -C6 alkanoyloxy-substituted C1 -C6 alkyl, a C1 -C6 alkylsulfonyloxy-(C1 -C6) alkyl, an azido -(C1 -C6) alkyl, a group of the formula: ##STR3384## an aminocarbonyloxy having optionally a C1 -C6 alkyl substituent, a C1 -C6 alkoxy, a C1 -C6 alkoxycarbonyl-substituted C1 -C6 alkoxy, a carboxy-substituted C1 -C6 alkoxy, an aminocarbonyl-(C1 -C6) alkoxy having optionally a C1 -C6 alkyl substituent, an amino-(C1 -C6) alkoxy having optionally a substituent selected from a C1 -C6 alkyl and a C1 -C6 alkanoyl, a phthalimido-substituted C1 -C6 alkoxy, hydroxyimino, a C1 -C6 alkanoyloxyimino, a C1 -C6 alkylidene, a halogen atom, azido, sulfoxyimino, a group of the formula: ##STR3385## wherein R81 is a hydrogen atom or a C1 -C6 alkyl, hydrazino, pyrrolyl, an amino-(C2 -C6) alkanoyloxy having optionally a C1 -C6 alkyl substituent, a group of the formula: ##STR3386## wherein A is as defined above, and R82 and R83 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl, a carbamoyl-substituted C1 -C6 alkyl, a hydroxy-substituted C1 -C6 alkyl, or a pyridyl-(C1 -C6) alkyl, or R82 and R83 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen, oxygen or sulfur atom wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, morpholino, and thiomorpholino, and has optionally a substituent selected from oxo, a C1 -C6 alkyl, a C1 -C6 alkanoyl, and carbamoyl, and a group of the formula: ##STR3387## wherein n is as defined above, and R14 and R15 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl, a C2 -C6 alkenyl, a C1 -C6 alkanoyl, a C3 -C8 cycloalkyl, an oxiranyl-substituted C1 -C6 alkyl, a C1 -C6 alkyl having 1 to 2 substituents selected from a C1 -C6 alkoxy, hydroxy and an amino having optionally a C1 -C6 alkyl substituent, a phenyl-(C1 -C6) alkyl, a pyridyl-(C1 -C6) alkyl, a C1 -C6 alkylsulfonyl, benzoyl, a C1 -C6 alkoxycarbonyl, anilinocarbonyl, an aminocarbonyl having optionally a C1 -C6 alkyl substituent, a cyano-substituted C1 -C6 alkyl, a C1 -C6 alkoxycarbonyl-substituted C1 -C6 alkyl, a carbamoyl-substituted C1 -C6 alkyl, a carboxy-substituted C1 -C6 alkyl, a tetrahydropyranyloxy-substituted C1 -C6 alkyl, a C1 -C6 alkanoyloxy-substituted C1 -C6 alkyl, a piperidinyl having optionally a phenyl-(C1 -C6) alkyl substituent on the piperidine ring, a halogen-substituted C1 -C6 alkanoyl, an imidazolyl-substituted C2 -C6 alkanoyl, an amino-(C2 -C6) alkanoyl having optionally a substituent selected from a C1 -C6 alkyl and a C1 -C6 alkoxycarbonyl, an aminocarbonyl-(C1 -C6) alkyl having optionally a C1 -C6 alkyl substituent, or a phenyl-(C1 -C6) alkoxycarbonyl, or R14 or R15 may bind together with the nitrogen atom to which they are bonded to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with a nitrogen or oxygen atom, wherein the heterocyclic group is one member selected from the group consisting of pyrrolidinyl, piperidinyl, piperazinyl, and morpholino, and may optionally have a substituent selected from a C1 -C6 alkyl, a phenyl-(C1 -C6) alkyl or a C1 -C6 alkanoyl.

56. The method according to claim 55, wherein p in the group of the formula: --(CH2)p -- is 3 and the group has no substituent.

57. The method according to claim 55, wherein p in the group of the formula: --(CH2)p -- is 3 and the group has a substituent of group of the formula: ##STR3388##

58. The method according to claim 55, wherein p in the group of the formula: --(CH2)p -- is 4 and the group has no substituent.

59. The method according to claim 55, wherein p in the group of the formula: --(CH2)p -- is 4 and the group has a substituent of a group of the formula: ##STR3389## wherein R14 and R15 and n are as defined in claim 55.

60. The method according to claim 55, wherein p in the group of the formula: --(CH2)p -- is 5.

61. The method according to claim 54, wherein q in the group of the formula: --CH═CH--(CH2)q -- is 1.

62. The method according to claim 54, wherein q in the group of the formula: --CH═CH--(CH2)q -- is 2.

63. The method according to claim 54, wherein q in the group of the formula: --CH═CH--(CH2)q -- is 3.

64. The method according to claim 57 or 59, wherein n in the group of the formula: ##STR3390## is 0, and R14 and R15 are the same or different and are each a hydrogen atom, a C1 -C6 alkyl, or a C3 -C8 cycloalkyl.

65. The method according to claim 62, wherein the heterocyclic group of the formula: ##STR3391## is 2,3,-dihydro-1 H-benzazepine.

66. The method according to claim 1, wherein the benzoheterocyclic compound is 5-dimethylamino-1- 4-(2-methylbenzoylamino)benzoyl!-2,3,4,5-tetrahydro-1H-benzazepine.

67. The method according to claim 1, wherein the benzoheterocyclic compound is 5-dimethylamino-1- 2-chloro-4-(2-methylbenzoylamino)benzoyl!-2,3,4,5-tetrahydro-1H-benzazepine.

68. The method according to claim 1, wherein the benzoheterocyclic compound is 5-methylamino-1- 2-chloro-4-(2-methylbenzoylamino)benzoyl!-2,3,4,5-tetrahydro-1H-benzazepine.

69. The method according to claim 1, wherein the benzoheterocyclic compound is 5-cyclopropylamino-1- 2-chloro-4-(2-methylbenzoylamino)benzoyl!-2,3,4,5-tetrahydro-1H-benzazepine.

70. The method according to claim 1, wherein the benzoheterocyclic compound is 5-cyclopropylamino-1- 2-chloro-4-(2-chlorobenzoylamino)benzoyl!-2,3,4,5-tetrahydro-1H-benzazepine.

71. The method according to claim 1, wherein the benzoheterocyclic compound is 5-dimethylamino-1- 2-methyl-4-(2-methylbenzoylamino)benzoyl!-2,3,4,5-tetrahydro-1H-benzazepine.

72. The method according to claim 1, wherein the benzoheterocyclic compound is 4-dimethylamino-1- 3-methoxy-4-(2-methylbenzoylamino)benzoyl!-1,2,3,4-tetrahydroquinoline.

73. The method according to claim 1, wherein the benzoheterocyclic compound is 7-chloro-5-methylamino-1- 4-(2-methylbenzoylamino)benzoyl!-2,3,4,5-tetrahydro-1H-benzazepine.

74. The method according to claim 1, wherein the benzoheterocyclic compound is 7-chloro-5-methylamino-1- 4-(2-chlorobenzoylamino)benzoyl!-2,3,4,5-tetrahydro-1H-benzazepine.

75. The method according to claim 1, wherein the benzoheterocyclic compound is 7-chloro-5-hydroxy-1- 2-methyl-4-(2-methylbenzoylamino)-benzoyl!-2,3,4,5-tetrahydro-1H-benzazepine.

76. The method according to claim 1, wherein the benzoheterocyclic compound is 7-chloro-5-hydroxy-1- 2-methoxy-4-(2-methylbenzoylamino)-benzoyl!-2,3,4,5-tetrahydro-1H-benzazepine.

77. The method according to claim 1, wherein the benzoheterocyclic compound is 7-fluoro-5-hydroxy-1- 2-chloro-4-(2-methylbenzoylamino)benzoyl!-2,3,4,5-tetrahydro-1H-benzazepine.

78. The method according to claim 1, wherein the benzoheterocyclic compound is 7-fluoro-5-hydroxymethyl-5-hydroxy-1- 2-chloro-4-(2-methylbenzoylamino)benzoyl!-2,3,4,5-tetrahydro-1H-benzazepine.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.